Cancer cells often use epigenetic changes to resist treatment, a major factor particularly in late-stage deaths from ovarian cancer. One potential epigenetic marker, DNA secondary structures known as G-quadruplexes (G4s), has recently gained attention; however, their presence and role in ovarian cancer had not been studied until now.